A systematic review of randomized trials of long-term opioid management for chronic non-cancer pain

Pain Physician

Volumn 14, Issue 2, 2011, Pages 91-121

  Manchikanti, Laxmaiah ^a,b   Ailinani, Hary ^c   Koyyalagunta, Dhanalakshmi ^d   Datta, Sukdeb ^e   Singh, Vijay ^f   Eriator, Ike ^g,h   Sehgal, Nalini ^i,j   Shah, Rinoo ^k   Benyamin, Ramsin ^l,m   Vallejo, Ricardo ^l,n   Fellows, Bert ^a   Christo, Paul J ^o  

^a PAIN MANAGEMENT CENTER OF PADUCAH   (United States)

^b University of Louisville School of Medicine   (United States)

^c North Shore Long Island Jewish Health System ^*  (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^f Pain Diagnostics Associates   (United States)

^g JACKSON STATE UNIVERSITY   (United States)

^h UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^j Department of Rehabilitation Rehabilitation Medicine   (United States)

^k WEILL CORNELL MEDICAL CENTER   (United States)

^l MILLENNIUM PAIN CENTER   (United States)

^m UNIVERSITY OF ILLINOIS   (United States)

ⁿ ILLINOIS STATE UNIVERSITY   (United States)

^o JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Adverse effects; Buprenorphine; Chronic non cancer pain; Fentanyl; Functional improvement; Hydrocodone; Hydromorphone; Methadone; Morphine; Opioid effectiveness; Opioid efficacy; Opioids; Oxycodone; Oxymorphone; Randomized trials; Significant pain relief; Systematic reviews; Tapentadol; Tramadol

Indexed keywords

BUPRENORPHINE; DEXTROMETHORPHAN; FENTANYL; HYDROCODONE; HYDROMORPHONE; METHADONE; MORPHINE; NALOXONE; NAPROXEN; NARCOTIC ANALGESIC AGENT; OXYCODONE; OXYMORPHONE; PLACEBO; TAPENTADOL; TRAMADOL;

ANALGESIA; BACKACHE; CHRONIC PAIN; COGNITIVE DEFECT; CONSTIPATION; DIABETIC NEUROPATHY; DIARRHEA; DIZZINESS; DOSAGE SCHEDULE COMPARISON; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; FATIGUE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEADACHE; HIP OSTEOARTHRITIS; HUMAN; HYPERHIDROSIS; KNEE OSTEOARTHRITIS; LONG TERM CARE; LOW BACK PAIN; META ANALYSIS; NAUSEA; OSTEOARTHRITIS; PAIN; PERIPHERAL EDEMA; PRURITUS; QUALITY CONTROL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEDATION; SIDE EFFECT; SOMNOLENCE; SWEATING; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VOMITING; XEROSTOMIA;

ANALGESICS, OPIOID; CHRONIC DISEASE; HUMANS; PAIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79952846471     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (232)

1. Manchikanti L, Benyamin R, Datta S, Vallejo R, Smith HS. Opioids in chronic noncancer pain. Expert Rev Neurother 2010; 10:775-789.
2. Trescot AM, Datta S, Glaser S, Sehgal N, Hansen H, Benyamin R, Patel S. Effectiveness of opioids in the treatment of chronic non-cancer pain. Pain Physician 2008; 11:S181-S200.
3. Trescot AM, Helm S, Hansen H, Benyamin R, Adlaka R, Patel S, Manchikanti L. Opioids in the management of chronic non-cancer pain: An update of American Society of Interventional Pain Physicians' (ASIPP) guidelines. Pain Physician 2008; 11:S5-S62.
4. Ballantyne JC. Opioid analgesia: Perspectives on right use and utility. Pain Physician 2007; 10:479-491.
5. Manchikanti L, Singh A. Therapeutic opioids: A ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician 2008; 11:S63-S88.
6. Manchikanti L, Fellows B, Ailinani H, Pampati V. Therapeutic use, abuse, and nonmedical use of opioids: A tenyear perspective. Pain Physician 2010; 13:401-435.
7. Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, Schoelles KM. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010; 1:CD006605.
8. Chou R, Huffman L. Use of Chronic Opioid Therapy in Chronic Noncancer Pain: Evidence Review. American Pain Society; Glenview, IL: 2009. www.ampainsoc.org/pub/pdf/Opioid_Final_Evidence_Report.pdf
9. Manchikanti L. Singh V, Datta S, Cohen SP, Hirsch JA. Comprehensive review of epidemiology, scope, and impact of spinal pain. Pain Physician 2009; 12:E35-E70.
10. Manchikanti L, Boswell MV, Singh V, Benyamin RM, Fellows B, Abdi S, Buenaventura RM, Conn A, Datta S, Derby R, Falco FJE, Erhart S, Diwan S, Hayek SM, Helm S, Parr AT, Schultz DM, Smith HS, Wolfer LR, Hirsch JA. Comprehensive evidence-based guidelines for interventional techniques in the management of chronic spinal pain. Pain Physician 2009; 12:699-802.
11. Bressler HB, Keyes WJ, Rochon PA, Badley E. The prevalence of low back pain in the elderly. A systematic review of the literature. Spine (Phila Pa 1976) 1999; 24:1813-1819.
12. Leigh JP, Sheetz RM. Prevalence of back pain among full-time United States workers. Br J In Med 1989; 46:651-657.
13. Pahor M, Guralnik JM, Wan JY. Lower body osteoarticular pain and dose of analgesic medications in older disabled women: The Women's Health and Aging Study. Am J Public Health 1999; 89:930-934.
14. Mailis-Gagnon A, Nicholson K, Yegneswaran B, Zurowski M. Pain characteristics of adults 65 years of age and older referred to a tertiary care pain clinic. Pain Res Manage 2008; 13:389-394.
15. The American Academy of Pain Medicine, the American Pain Society. The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin J Pain 1997; 13:6-8.
16. British Pain Society. Opioids for persistent pain: Good practice. A consensus statement prepared on behalf of the British Pain Society, the Faculty of Pain Medicine and the Royal College of Anaesthetists, the Royal College of General Practitioners and the Faculty of Addictions of the Royal College of Psychiatrists. The British Pain Society, London, UK, January 2010.
17. Jovey RD, Ennis J, Gardner-Nix J, Goldman B, Hays H, Lynch M, Moulin D; Canadian Pain Society. Use of opioid analgesics for the treatment of chronic noncancer pain--a consensus statement and guidelines from the Canadian Pain Society, 2002. Pain Res Manage 2003; 8:3A-28A.
18. Martell BA, O'Connor PG, Kerns RD, Beck WC, Morales KH, Kosten TR, Fiellen DA. Systematic review: Opioid treatment for chronic back pain: Prevalence, efficacy, and association with addiction. Ann Intern Med 2007; 146:116-127.
19. Chou R, Clark E, Helfand M. Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: A systematic review. J Pain Symptom Manage 2003; 26:1026-1048.
20. Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: Systematic review of efficacy and safety. Pain 2004; 112:372-380.
21. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: A meta-analysis of effectiveness and side effects. Can Med Assoc J 2006; 174:1589-1594.
22. Eisenberg E, McNicol E, Carr DB. Opioids for neuropathic pain (review). Cochrane Database Syst Rev 2006, 3:CD006146.
23. Deshpande A, Furlan A, Mailis-Gagnon A, Atlas S, Turk D. Opioids for chronic low back pain (review). Cochrane Database Syst Rev 2007; 3:CD004959.
24. Cepeda MS, Camargo F, Zea CLV. Tramadol for osteoarthritis. Cochrane Database Syst Rev 2006 3:CD005522.
25. Devulder J, Richarz U, Nataraja SH. Impact of long-term use of opioids on quality of life in patients with chronic, non-malignant pain. Curr Med Res Opin 2005; 21:1555-1568.
26. Hollingshead J, Duhmke R, Cornblath D. Tramadol for neuropathic pain. Cochrane Database Syst 2006; 3:CD003726.
27. Moore RA, McQuay H. Prevalence of opioid adverse events in chronic non-malignant pain: Systematic review of ran domised trials of oral opioids. Arthritis Res Ther 2005; 7:R1046-R1051.
28. Dole V. What we have learned from three decades of methadone maintenance treatment. Drug & Alcohol Review 1994; 13:3-4.
29. Brecher E, Editors of Consumer Reports Magazine. Chapter 15. How well does methadone maintenance work? In: The Consumers Union Report on Licit and Illicit Drugs. Schaffer Library of Drug Policy, 1972. www.druglibrary.org/schaffer/library/studies/cu/CU15.html
30. Tennant FS J, Uelman GF. Narcotic maintenance for chronic pain: Medical and legal guidelines. Postgrad Med 1983; 73:81-94.
31. Bouckoms AJ, Masand P, Murray GB, Cassem EH, Stern TA, Tesar GE. Chronic nonmalignant pain treatment with long-term analgesics. Ann Clin Psychiatry 1992; 4:185-192.
32. Manchikanti L. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 1: Introduction and general considerations. Pain Physician 2008; 11:161-186.
33. Manchikanti L, Hirsch JA, Smith HS. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 2: Randomized controlled trials. Pain Physician 2008; 11:717-773.
34. Manchikanti L, Benyamin RM, Helm S, Hirsch JA. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 3: Systematic reviews and meta-analysis of randomized trials. Pain Physician 2009; 12:35-72.
35. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Quality of reporting of meta-analyses. Lancet 1999; 354:1896-1900.
36. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. Ann Intern Med 2009; 151:W65-W94.
37. van Tulder M, Furlan A, Bombardier C, Bouter L; Editorial Board of the Cochrane Collaboration Back Review Group. Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group. Spine (Phila Pa 1976) 2003; 28:1290-1299.
38. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, Mc-Quay HJ. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996; 17:1-12.
39. Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-188.
40. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gøtzsche PC, Lang T; CONSORT GROUP (Consolidated Standards of Reporting Trials). The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med 2001; 134:663-694.
41. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340:c869.
42. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-560.
43. Farrar JT. What is clinically meaningful: Outcome measures in pain clinical trials. Clin J Pain 2000; 16:S106-S112.
44. Salaffi F, Stancati A, Silvestri CA, Ciapetti A, Grassi W. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain 2004; 8:283-291.
45. Manchikanti L, Singh V, Smith HS, Hirsch JA. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 4: Observational studies. Pain Physician 2009; 12:73-108.
46. Hagg O, Fritzell P, Nordwall A. The clinical importance of changes in outcome scores after treatment for chronic low back pain. Eur Spine J 2003; 12:12-20.
47. Carragee EJ, Chen I. Minimum acceptable outcomes after lumbar spinal fusion. Spine J 2010; 10:313-320.
48. Gatchel RJ, Mayer TG. Testing minimal clinically important difference: Consensus or conundrum? Spine J 2010; 10:321-327.
49. Manchikanti L, Singh V, Falco FJE, Cash KA, Pampati V. Evaluation of lumbar facet joint nerve blocks in managing chronic low back pain: A randomized, doubleblind, controlled trial with a 2-year follow-up. Int J Med Sci 2010; 7:124-135.
50. Manchikanti L, Singh V, Falco FJE, Cash KA, Fellows B. Comparative outcomes of a 2-year follow-up of cervical medial branch blocks in management of chronic neck pain: A randomized, double-blind controlled trial. Pain Physician 2010; 437-450.
51. Harbord R, Higgins J. METAREG: Stata module to perform meta-analysis regression. Boston College Dept of Econ, Boston, MA. www.econpapers.org/software/bocbocode/s446201.htm.
52. SPSS Statistics Software Standard Version (for Windows). Version 9.0.1, Chicago, IL: SPSS Inc; 1999.
53. Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 2006; 11:193-206.
54. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, Atkins D; Methods Work Group, Third US Preventive Services Task Force. Current methods of the US Preventive Services Task Force. Am J Prevent Med 2001; 20:21-35.
55. Adler L, McDonald C, O'Brien C, Wilson M. A comparison of once-daily tramadol with normal release tramadol in the treatment of pain in osteoarthritis. J Rheumatol 2002; 29:2196-2199.
56. Aqua K, Gimbel JS, Singla N, Ma T, Ahdieh H, Kerwin R. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: A randomized, doubleblind, active-and placebo-controlled, parallel-group trial. Clin Ther 2007; 29:1000-1012.
57. Aurilio C, Pace MC, Passavanti MB, Paladini A, Maisto M, Iannotti M, Pota V, D'amora E, Sansone P, Barbarisi M. Treatment of ischemic pain in patients suffering from peripheral vasculopathy with transdermal buprenorphine plus epidural morphine with ropivacaine vs. epidural morphine with ropivacaine. Pain Pract 2009; 9:105-114.
58. Beaulieu AD, Peloso P, Bensen W, Clark AJ, Watson CP, Gardner-Nix J, Thomson G, Piraino PS, Eisenhoffer J, Harsanyi Z, Darke AC. A randomized, double-blind, 8-week crossover study of once-daily controlled-release tramadol versus immediate-release tramadol taken as needed for chronic noncancer pain. Clin Ther 2007; 29:49-60.
59. Beaulieu AD, Peloso PM, Haraoui B, Bensen W, Thomson G, Wade J, Quigley P, Eisenhoffer J, Harsanyi Z, Darke AC. Once-daily, controlled-release tramadol and sustained-release diclofenac relieve chronic pain due to osteoarthritis: A randomized controlled trial. Pain Res Manag 2008; 13:103-110.
60. Bodalia B, McDonald CJ, Smith KJ, O'Brien C, Cousens L. A comparison of the pharmacokinetics, clinical efficacy, and tolerability of once-daily tramadol tablets with normal release tramadol capsules. J Pain Symptom Manage 2003; 25:142-149.
61. Caldwell JR, Hale ME, Boyd RE, Hague JM, Iwan T, Shi M, Lacouture PG. Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: A double blind, randomized, multicenter, placebo controlled trial. J Rheumatol 1999; 26:862-869.
62. Caldwell JR, Rapoport RJ, Davis JC, Offenberg HL, Marker HW, Roth SH, Yuan W, Eliot L, Babul N, Lynch PM. Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: Results from a randomized, placebo-controlled, doubleblind trial and an open-label extension trial. J Pain Symptom Manage 2002; 23:278-291.
63. Chang AK, Bijur PE, Baccelieri A, Gallagher EJ. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: A prospective, randomized, double-blind clinical trial. Am J Geriatr Pharmacother 2009; 7:1-10.
64. Chindalore VL, Craven RA, Yu KP, Butera PG, Burns LH, Friedmann N. Adding ultralow-dose naltrexone to oxycodone enhances and prolongs analgesia: A randomized, controlled trial of Oxytrex. J Pain 2005; 6:392-399.
65. Cowan DT, Wilson-Barnett J, Griffiths P, Vaughan DJ, Gondhia A, Allan LG. A randomized, double-blind, placebo controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine. Pain Med 2005; 6:113-121.
66. Daniels SE, Upmalis D, Okamoto A, Lange C, Häeussler J. A randomized, double-blind, phase III study comparing multiple doses of tapentadol IR, oxycodone IR, and placebo for postoperative (bunionectomy) pain. Curr Med Res Opin 2009; 25:765-776.
67. Daniels S, Casson E, Stegmann JU, Oh C, Okamoto A, Rauschkolb C, Upmalis D. A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain. Curr Med Res Opin 2009; 25:1551-1561.
68. Etropolski MS, Okamoto A, Shapiro DY, Rauschkolb C. Dose conversion between tapentadol immediate and extended release for low back pain. Pain Physician 2010; 13:61-70.
69. Frank B, Serpell MG, Hughes J, Matthews JN, Kapur D. Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: Randomised, crossover, double blind study. BMJ 2008; 336:199-201.
70. Gatti A, Reale C, Occhioni R, Luzi M, Canneti A, De Polo C, Gubernari M, Mammucari M, Fabrizio Sabato A. Standard therapy with opioids in chronic pain management: ORTIBER study. Clin Drug Investig 2009; 29:17-23.
71. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005; 352:1324-1334.
72. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: A randomized controlled trial. Neurology 2003; 60:927-934.
73. Gordon A, Rashiq S, Moulin DE, Clark AJ, Beaulieu AD, Eisenhoffer J, Piraino PS, Quigley P, Harsanyi Z, Darke AC. Buprenorphine transdermal system for opioid therapy in patients with chronic low back pain. Pain Res Manag 2010; 15:169-178.
74. Gordon A, Callaghan D, Spink D, Cloutier C, Dzongowski P, O'Mahony W, Sinclair D, Rashiq S, Buckley N, Cohen G, Kim J, Boulanger A, Piraino PS, Eisenhoffer J, Harsanyi Z, Darke AC, Michalko KJ. Buprenorphine transdermal system in adults with chronic low back pain: A randomized, double-blind, placebocontrolled crossover study, followed by an open-label extension phase. Clin Ther 2010; 32:844-860.
75. Gould EM, Jensen MP, Victor TW, Gammaitoni AR, White RE, Galer BS. The pain quality response profile of oxymorphone extended release in the treatment of low back pain. Clin J Pain 2009; 25:116-122.
76. Grosset AB, Roberts MS, Woodson ME, Shi M, Swanton RE, Reder RF, Buckley BJ. Comparative efficacy of oral extended-release hydromorphone and immediate-release hydromorphone in patients with persistent moderate to severe pain: Two randomized controlled trials. J Pain Symptom Manage 2005; 29:584-594.
77. Hale ME, Speight K, Harsanyi Z, Iwan T, Slagle N, Lacouture P, Darke A. Efficacy of 12 hourly controlled-release codeine compared with as required dosing of acetaminophen plus codeine in patients with chronic low back pain. Pain Res Manag 1997; 2:33-38.
78. Hale ME, Dvergsten C, Gimbel J. Efficacy and safety of oxymorphone extended release in chronic low back pain: Results of a randomized, double-blind, placebo-and active-controlled phase III study. J Pain 2005; 6:21-28.
79. Hale ME, Fleischmann R, Salzman R, Wild J, Iwan T, Swanton RE, Kaiko RF, Lacouture PG. Efficacy and safety of controlled-release versus immediate-release oxycodone: Randomized, doubleblind evaluation in patients with chronic back pain. Clin J Pain 1999; 15:179-183.
80. Hale ME, Tudor IC, Khanna S, Thipphawong J. Efficacy and tolerability of oncedaily OROS hydromorphone and twicedaily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: Results of a 6-week, randomized, open-label, noninferiority analysis. Clin Ther 2007; 29:874-888.
81. Hamann S, Sloan P. Oral naltrexone to enhance analgesia in patients receiving continuous intrathecal morphine for chronic pain: A randomized, doubleblind, prospective pilot study. J Opioid Manag 2007; 3:137-144.
82. Harati Y, Gooch C, Swenson M, Edelman SV, Greene D, Raskin P, Donofrio P, Cornblath D, Olson WH, Kamin M. Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy. J Diabetes Complications 2000; 14:65-70.
83. Harke H, Gretenkort P, Ladleif HU, Rahman S, Harke O. The response of neuropathic pain and pain in complex regional pain syndrome I to carbamazepine and sustained-release morphine in patients pretreated with spinal cord stimulation: A double-blinded randomized study. Anesth Analg 2001; 92:488-495.
84. Hartrick C, Van Hove I, Stegmann JU, Oh C, Upmalis D. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: A 10-day, phase III, randomized, double-blind, active-and placebo-controlled study. Clin Ther 2009; 31:260-271.
85. Huse E, Larbig W, Flor H, Birbaumer N. The effect of opioids on phantom limb pain and cortical reorganization. Pain 2001; 90:47-55.
86. James IG, O'Brien CM, McDonald CJ. A randomized, double-blind, doubledummy comparison of the efficacy and tolerability of low-dose transdermal buprenorphine (BuTrans seven-day patches) with buprenorphine sublingual tablets (Temgesic) in patients with osteoarthritis pain. J Pain Symptom Manage 2010; 40:266-278.
87. Jensen EM, Ginsberg F. Tramadol versus dextropropoxyphene in the treatment of osteoarthritis: A short term doubleblind study. Drug Invest 1994; 8:211-218.
88. Kalso E, Simpson KH, Slappendel R, Dejonckheere J, Richarz U. Predicting longterm response to strong opioids in patients with low back pain: Findings from a randomized, controlled trial of transdermal fentanyl and morphine. BMC Med 2007; 5:39.
89. Katz N, Sun S, Johnson F, Stauffer J. ALO-01 (morphine sulfate and naltrexone hydrochloride) extended-release capsules in the treatment of chronic pain of osteoarthritis of the hip or knee: Pharmacokinetics, efficacy, and safety. J Pain 2010; 11:303-311.
90. Khoromi S, Cui L, Nackers L, Max MB. Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain. Pain 2007; 130:66-75.
91. Kivitz A, Ma C, Ahdieh H, Galer BS. A 2-week, multicenter, randomized, doubleblind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. Clin Ther 2006; 28:352-364.
92. Kleinert R, Lange C, Steup A, Black P, Goldberg J, Desjardins P. Single dose analgesic efficacy of tapentadol in postsurgical dental pain: The results of a randomized, double-blind, placebocontrolled study. Anesth Analg 2008; 107:2048-2055.
93. Landau CJ, Carr WD, Razzetti AJ, Sessler NE, Munera C, Ripa SR. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: A multicenter, 5-week runin and randomized, double-blind maintenance-of-analgesia study. Clin Ther 2007; 29:2179-2193.
94. Lange B, Kuperwasser B, Okamoto A, Steup A, Häufel T, Ashworth J, Etropolski M. Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain. Adv Ther 2010; 27:381-399.
95. Langford R, McKenna F, Ratcliffe S, Vojtassák J, Richarz U. Transdermal fentanyl for improvement of pain and functioning in osteoarthritis: A randomized, placebo-controlled trial. Arth Rheum 2006; 54:1829-1837.
96. Likar R, Lorenz V, Korak-Leiter M, Kager I, Sittl R. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: A singlesite, Phase III, randomized, open-label, crossover comparison. Clin Ther 2007; 29:1591-1606.
97. Litkowski LJ, Christensen SE, Adamson DN, Van Dyke T, Han SH, Newman KB. Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: A randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model. Clin Ther 2005; 27:418-429.
98. Ma K, Jiang W, Zhou Q, Du DP. The efficacy of oxycodone for management of acute pain episodes in chronic neck pain patients. Int J Clin Pract 2008; 62:241-247.
99. Malonne H, Coffiner M, Sonet B, Sereno A, Vanderbist F. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: A multicenter, randomized, double-blind, placebo-controlled study. Clin Ther 2004; 26:1774-1782.
100. Malonne H, Coffiner M, Fontaine D, Sonet B, Sereno A, Peretz A, Vanderbist F. Long-term tolerability of tramadol LP, a new once-daily formulation, in patients with osteoarthritis or low back pain. J Clin Pharm Ther 2005; 30:113-120.
101. Matsumoto AK, Babul N, Ahdieh H. Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: results of a randomized, doubleblind, placebo-and active-controlled phase III trial. Pain Med 2005; 6:357-366.
102. Max MB, Schafer SC, Culnane M, Dubner R, Gracely RH. Association of pain relief with drug side effects in postherpetic neuralgia: A single-dose study of clonidine, codeine, ibuprofen, and placebo. Clin Pharmacol Ther 1988; 43:363-371.
103. McIlwain H, Ahdieh H. Safety, tolerability, and effectiveness of oxymorphone extended release for moderate to severe osteoarthritis pain: A one-year study. Am J Ther 2005; 12:106-112.
104. Morley JS, Bridson J, Nash TP, Miles JB, White S, Makin MK. Low-dose methadone has an analgesic effect in neuropathic pain: A double-blind randomized controlled crossover trial. Palliat Med 2003; 17:576-587.
105. Moulin DE, Iezzi A, Amireh R, Sharpe WK, Boyd D, Merskey H. Randomised trial of oral morphine for chronic noncancer pain. Lancet 1996; 347:143-147.
106. Mullican WS, Lacy JR; TRAMAP-ANAG-006 Study Group. Tramadol/acetaminophen combination tablets and codeine/acetaminophen combination capsules for the management of chronic pain: A comparative trial. Clin Ther 2001; 23:1429-1445.
107. Munera C, Drehobl M, Sessler NE, Landau C. A randomized, placebo-controlled, double-blinded, parallel-group, 5-week study of buprenorphine transdermal system in adults with osteoarthritis. J Opioid Manag 2010; 6:193-202.
108. Nicholson B, Ross E, Weil A, Sasaki J, Sacks G. Treatment of chronic moderate-to-severe non-malignant pain with polymer-coated extended-release morphine sulfate capsules. Curr Med Res Opin 2006; 22:539-550.
109. Niemann T, Madsen LG, Larsen S, Thorsgaard N. Opioid treatment of painful chronic pancreatitis. Int J Pancreatol 2000; 27:235-240.
110. Norrbrink C, Lundeberg T. Tramadol in neuropathic pain after spinal cord injury: A randomized, double-blind, placebo-controlled trial. Clin J Pain 2009; 25:177-184.
111. Palangio M, Morris E, Doyle RT Jr, Dornseif BE, Valente TJ. Combination hydrocodone and ibuprofen versus combination oxycodone and acetaminophen in the treatment of moderate or severe acute low back pain. Clin Ther 2002; 24:87-99.
112. Parris WC, Johnson BW Jr, Croghan MK, Moore MR, Khojasteh A, Reder RF, Kaiko RF, Buckley BJ. The use of controlledrelease oxycodone for the treatment of chronic cancer pain: A randomized, double-blind study. J Pain Symptom Manage 1998; 16:205-211.
113. Paulson DM, Kennedy DT, Donovick RA, Carpenter RL, Cherubini M, Techner L, Du W, Ma Y, Schmidt WK, Wallin B, Jackson D. Alvimopan: An oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction--a 21-day treatmentrandomized clinical trial. J Pain 2005; 6:184-192.
114. Perrot S, Krause D, Crozes P, Naïm C; GRTF-ZAL-1 Study Group. Efficacy and tolerability of paracetamol/tramadol (325 mg/37.5 mg) combination treatment compared with tramadol (50 mg) monotherapy in patients with subacute low back pain: A multicenter, randomized, double-blind, parallel-group, 10-day treatment study. Clin Ther 2006; 28:1592-1606.
115. Petrone D, Kamin M, Olson W. Slowing the titration rate of tramadol HCl reduces the incidence of discontinuation due to nausea and/or vomiting: A doubleblind randomized trial. J Clin Pharm Ther 1999; 24:115-123.
116. Portenoy RK, Messina J, Xie F, Peppin J. Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: A randomized, placebo-controlled study. Curr Med Res Opin 2007; 23:223-233.
117. Raber M, Hofmann S, Junge K, Momberger H, Kuhn D. Analgesic efficacy and tolerability of tramadol 100 mg sustained-release capsules in patients with moderate to severe chronic low back pain. Clin Drug Inves 1999; 17:415-423.
118. Raja SN, Haythornthwaite JA, Pappagallo M, Clark MR, Travison TG, Sabeen S, Royall RM, Max MB. Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology 2002; 59:1015-1021.
119. Ralphs JA, Williams AC, Richardson PH, Pither CE, Nicholas MK. Opiate reduction in chronic pain patients: A comparison of patient-controlled reduction and staff controlled cocktail methods. Pain 1994; 56:279-288.
120. Rauck RL, Bookbinder SA, Bunker TR, Alftine CD, Ghalie R, Negro-Vilar A, de Jong E, Gershon S. The ACTION study: a randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin) for the treatment of chronic, moderate to severe low back pain. J Opioid Manag 2006; 2:155-166. Erratum in: J Opioid Manag 2006; 2:276.
121. Roth SH, Fleischmann RM, Burch FX, Dietz F, Bockow B, Rapoport RJ, Rutstein J, Lacouture PG. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: Placebocontrolled trial and long-term evaluation. Arch Intern Med 2000; 160:853-860.
122. Rowbotham MC, Twilling L, Davies PS, Reisner L, Taylor K, Mohr D. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 2003; 348:1223-1232.
123. Ruoff GE. Slowing the initial titration rate of tramadol improves tolerability. Pharmacother 1999; 19:88-93.
124. Ruoff GE, Rosenthal N, Jordan D, Karim R, Kamin M; Protocol CAPSS-112 Study Group. Tramadol/acetaminophen combination tablets for the treatment of chronic lower back pain: A multicenter, randomized, double-blind, placebo-controlled outpatient study. Clin Ther 2003; 25:1123-1141.
125. Salzman RT, Roberts MS, Wild J, Fabian C, Reder RF, Goldenheim PD. Can a controlled release oral dose form of oxycodone be used as readily as an immediate release form for the purpose of titrating to stable pain control? J Pain Sympt Manage 1999; 18:271-279.
126. Sandner-Kiesling A, Leyendecker P, Hopp M, Tarau L, Lejcko J, Meissner W, Sevcik P, Hakl M, Hrib R, Uhl R, Dürr H, Reimer K. Long-term efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of non-cancer chronic pain. Int J Clin Pract 2010; 64:763-774.
127. Simpson DM, Messina J, Xie F, Hale ME. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: A multicenter, randomized, double-blind, placebo-controlled study. Clin Ther 2007; 29:588-601.
128. Sindrup SH, Madsen C, Brøsen K, Jensen TS. The effect of tramadol in pain ful polyneuropathy in relation to serum drug and metabolite levels. Clin Pharmacol Ther 1999; 66:636-641.
129. Sindrup SH, Andersen G, Madsen C, Smith T, Brøsen K, Jensen TS. Tramadol relieves pain and allodynia in polyneuropathy: A randomised, double-blind, controlled trial. Pain 1999; 83:85-90.
130. Sorge J, Stadler T. Comparison of the analgesic efficacy and tolerability of tramadol 100 mg sustained-release tablets and tramadol 50 mg capsules for the treatment of chronic low back pain. Clin Drug Invest 1997; 14:157-164.
131. Sorge J, Sittl R. Transdermal buprenorphine in the treatment of chronic pain: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled study. Clin Ther 2004; 26:1808-1820.
132. Stegmann JU, Weber H, Steup A, Okamoto A, Upmalis D, Daniels S. The efficacy and tolerability of multiple-dose tapentadol immediate release for the relief of acute pain following orthopedic (bunionectomy) surgery. Curr Med Res Opin 2008; 24:3185-3196.
133. Tessaro L, Bandieri E, Costa G, Fornasier G, Iorno V, Pizza C, Pastacaldi G, Micheletto G. Use of oxycodone controlledrelease immediately after NSAIDs: A new approach to obtain good pain control. Eur Rev Med Pharmacol Sci 2010; 14:113-121.
134. Thorne C, Beaulieu AD, Callaghan DJ, O'Mahony WF, Bartlett JM, Knight R, Kraag GR, Akhras R, Piraino PS, Eisenhoffer J, Harsanyi Z, Darke AC. A randomized, double-blind, crossover comparison of the efficacy and safety of oral controlled-release tramadol and placebo in patients with painful osteoarthritis. Pain Res Manag 2008; 13:93-102.
135. Vorsanger G, Xiang J, Jordan D, Farrell J. Post hoc analysis of a randomized, double-blind, placebo-controlled efficacy and tolerability study of tramadol extended release for the treatment of osteoarthritis pain in geriatric patients. Clin Ther 2007; 29:S2520-S2535.
136. Vorsanger G, Xiang J, Okamoto A, Upmalis D, Moskovitz B. Evaluation of study discontinuations with tapentadol immediate release and oxycodone immediate release in patients with low back or osteoarthritis pain. J Opioid Manage 2010; 6:169-179.
137. Wallace M, Skowronski R, Khanna S, Tudor IC, Thipphawong J. Efficacy and safety evaluation of once-daily OROS hydromorphone in patients with chronic low back pain: A pilot open-label study (DO-127). Curr Med Res Opin 2007; 23:981-999.
138. Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 1998; 50:1837-1841.
139. Watson CP, Moulin D, Watt-Watson J, Gordon A, Eisenhoffer J. Controlled-release oxycodone relieves neuropathic pain: A randomized controlled trial in painful diabetic neuropathy. Pain 2003; 105:71-78.
140. Webster L, Jansen JP, Peppin J, Lasko B, Irving G, Morlion B, Snidow J, Pierce A, Mortensen E, Kleoudis C, Carter E. Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose finding study in subjects taking opioids for chronic non-cancer pain. Pain 2008; 137:428-440.
141. Wilder-Smith CH, Hill L, Spargo K, Kalla A. Treatment of severe pain from osteoarthritis with slow-release tramadol or dihydrocodeine in combination with NSAID's: A randomised study comparing analgesia, antinociception and gastrointestinal effects. Pain 2001; 91:23-31.
142. Zautra AJ, Smith BW. Impact of controlled release oxycodone on efficacy beliefs and coping efforts among osteoarthritis patients with moderate to severe pain. Clin J Pain 2005; 21:471-477.
143. Afilalo M, Etropolski MS, Kuperwasser B, Kelly K, Okamoto A, Van Hove I, Steup A, Lange B, Rauschkolb C, Haeussler J. Efficacy and safety of tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: A randomized, double-blind, placebo-and active-controlled phase III study. Clin Drug Investig 2010; 30:489-505.
144. Allan L, Richarz U, Simpson K, Slappendel R. Transdermal fentanyl versus sustained release oral morphine in strongopioid naïve patients with chronic low back pain. Spine(Phila Pa 1976) 2005; 30:2484-2490.
145. Babul N, Noveck R, Chipman H, Roth SH, Gana T, Albert K. Efficacy and safety of extended-release, once-daily tramadol in chronic pain: A randomized 12-week clinical trial in osteoarthritis of the knee. J Pain Symptom Manage 2004; 28:59-71.
146. Binsfeld H, Szczepanski L, Waechter S, Richarz U, Sabatowski R. A randomized study to demonstrate noninferiority of once-daily OROS(®) hydromorphone with twice-daily sustained-release oxycodone for moderate to severe chronic noncancer pain. Pain Pract 2010; 10:404-415.
147. Burch F, Fishman R, Messina N, Corser B, Radulescu F, Sarbu A, Craciun-Nicodin MM, Chiriac R, Beaulieu A, Rodrigues J, Beignot-Devalmont P, Duplan A, Robertson S, Fortier L, Bouchard S. A comparison of the analgesic efficacy of tramadol Contramid OAD versus placebo in patients with pain due to osteoarthritis. J Pain Symptom Manage 2007; 34:328-338.
148. Buynak R, Shapiro DY, Okamoto A, Van Hove I, Rauschkolb C, Steup A, Lange B, Lange C, Etropolski M. Efficacy and safety of tapentadol extended release for the management of chronic low back pain: Results of a prospective, randomized, double-blind, placebo-and activecontrolled Phase III study. Expert Opin Pharmacother 2010; 11:1787-1804.
149. Galer BS, Lee D, Ma T, Nagle B, Schlagheck TG. MorphiDex (morphine sulfate/dextromethorphan hydrobromide combination) in the treatment of chronic pain: Three multicenter, randomized, double blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance. Pain 2005; 115:284-295.
150. Gana TJ, Pascual ML, Fleming RR, Schein JR, Janagap CC, Xiang J, Vorsanger GJ; 023 Study Group. Extended-release tramadol in the treatment of osteoarthritis: A multicenter, randomized, doubleblind, placebo-controlled clinical trial. Curr Med Res Opin 2006; 22: 1391-1401.
151. Hale ME, Ahdieh H, Ma T, Rauck R; Oxymorphone ER Study Group 1. Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid experienced patients: A 12-week, randomized, double-blind, placebo-controlled study. J Pain 2007; 8:175-184.
152. Hale ME, Upmalis D, Okamoto A, Lange C, Rauschkolb C. Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: A randomized, double-blind study. Curr Med Res Opin 2009; 25:1095-1104.
153. Hanna M, O'Brien C, Wilson M. Prolonged release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients. Eur J Pain 2008; 12 804-813.
154. Jamison RN, Raymond SA, Slawsby EA, Nedeljkovic SS, Katz NP. Opioid therapy for chronic noncancer back pain. A randomized prospective study. Spine (Phila Pa 1976) 1998; 23:2591-2600.
155. Karlsson M, Berggren AC. Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: A 12-week, randomized, open-label, controlled, parallel-group noninferiority study. Clin Ther 2009; 31:503-513.
156. Katz N, Rauck R, Ahdieh H, Ma T, Gerritsen van der Hoop R, Kerwin R, Podolsky G. A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid naive patients with chronic low back pain. Curr Med Res Opin 2007; 23:117-128.
157. Markenson JA, Croft J, Zhang PG, Richards P. Treatment of persistent pain associated with osteoarthritis with controlled-release oxycodone tablets in a randomized controlled clinical trial. Clin J Pain 2005; 21:524-535.
158. Mongin G, Yakusevich V, Köpe A, Shostak N, Pikhlak E, Popdán L, Simon J, Navarro C, Fortier L, Robertson S, Bouchard S. Efficacy and safety assessment of a novel once-daily tablet formulation of tramadol: A randomised, controlled study versus twice daily tramadol in patients with osteoarthritis of the knee. Clin Drug Invest 2004; 24:545-558.
159. Nicholson B, Ross E, Sasaki J, Weil A. Randomized trial comparing polymercoated extended-release morphine sulphate to controlled-release oxycodone HCI in moderate to severe nonmalignant pain. Curr Med Res Opin 2006; 22:1503-1514.
160. Rauck RL, Bookbinder SA, Bunker TR, Alftine CD, Gershon S, de Jong E, Negro-Vilar A, Ghalie R. A randomized, open-label, multicenter trial comparing once-aday AVINZA (morphine sulfate extended-release capsules) versus twice-aday OxyContin (oxycodone hydrochloride controlled-released tablets) for the treatment of chronic, moderate to severe low back pain: Improved physical functioning in the ACTION trial. J Opioid Manage 2007; 3:35-43.
161. Simpson K, Leyendecker P, Hopp M, Müller-Lissner S, Löwenstein O, De Andrés J, Troy Ferrarons J, Bosse B, Krain B, Nichols T, Kremers W, Reimer K. Fixedratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain. Curr Med Res Opin 2008; 24:3503-3512.
162. Vondrackova D, Leyendecker P, Meissner W, Hopp M, Szombati I, Hermanns K, Ruckes C, Weber S, Grothe B, Fleischer W, Reimer K. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain. J Pain 2008; 9:1144-1154.
163. Vorsanger GJ, Xiang J, Gana TJ, Pascual ML, Fleming RR. Extended-release tramadol (tramadol ER) in the treatment of chronic low back pain. J Opioid Manag 2008; 4:87-97.
164. Webster LR, Butera PG, Moran LV, Wu N, Burns LH, Friedmann N. Oxytrex minimizes physical dependence while providing effective analgesia: A randomized controlled trial in low back pain. J Pain 2006; 7:937-946.
165. Wild JE, Grond S, Kuperwasser B, Gilbert J, McCann B, Lange B, Steup A, Häufel T, Etropolski MS, Rauschkolb C, Lange R. Long-term safety and tolerability of tapentadol extended release for the management of chronic low back pain or osteoarthritis pain. Pain Pract 2010; 10:416-427.
166. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, Donovan MI, Fishbain DA, Foley KM, Fudin J, Gilson AM, Kelter A, Mauskop A, O'Connor PG, Passik SD, Pasternak GW, Portenoy RK, Rich BA, Roberts RG, Todd KH, Miaskowski C; American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009; 10:113-130.
167. Chou R, Fanciullo GJ, Fine PG, Miaskowski C, Passik SD, Portenoy RK. Opioids for chronic noncancer pain: Prediction and identification of aberrant drug-related behaviors: A review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009; 10:131-146.
168. Chou R, Ballantyne JC, Fanciullo GJ, Fine PG, Miaskowski C. Research gaps on use of opioids for chronic noncancer pain: Findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009; 10:147-159.
169. Chou R, Huffman L. Evaluation and Management of Low Back Pain: Evidence Review. American Pain Society, Glenview, IL, 2009.
170. Chou R, Baisden J, Carragee EJ, Resnick DK, Shaffer WO, Loeser JD. Surgery for low back pain: A review of the evidence for an American Pain Society Clinical Practice Guideline. Spine (Phila Pa 1976) 2009; 34:1094-1109.
171. Chou R, Atlas SJ, Stanos SP, Rosenquist RW. Nonsurgical interventional therapies for low back pain: A review of the evidence for an American Pain Society clinical practice guideline. Spine (Phila Pa 1976) 2009; 34:1078-1093.
172. Chou R, Loeser JD, Owens DK, Rosenquist RW, Atlas SJ, Baisden J, Carragee EJ, Grabois M, Murphy DR, Resnick DK, Stanos SP, Shaffer WO, Wall EM; American Pain Society Low Back Pain Guideline Panel. Interventional therapies, surgery, and interdisciplinary rehabilitation for low back pain: An evidencebased clinical practice guideline from the American Pain Society. Spine (Phila Pa 1976) 2009; 34:1066-1077.
173. Manchikanti L, Datta S, Derby R, Wolfer LR, Benyamin RM, Hirsch JA. A critical review of the American Pain Society clinical practice guidelines for interventional techniques: Part 1. Diagnostic interventions. Pain Physician 2010; 13:E141-E174.
174. Manchikanti L, Datta S, Gupta S, Munglani R, Bryce DA, Ward SP, Benyamin RM, Sharma ML, Helm II S, Fellows B, Hirsch JA. A critical review of the American Pain Society clinical practice guidelines for interventional techniques: Part 2. Therapeutic interventions. Pain Physician 2010; 13:E215-E264.
175. Chou R. Critiquing the critiques: The American Pain Society guideline and the American Society of Interventional Pain Physicians response to it. Pain Physician 2010; in submission.
176. Manchikanti L. In response: Critiquing the critiques: The American Pain Society guideline and the American Society of Interventional Pain Physicians response to it. Pain Physician 2010; in submission; author reply in submission.
177. American College of Occupational and Environmental Medicine (ACOEM) Low back Disorders. In Occupational Medicine Practice Guidelines: Evaluation and Management of Common Health Problems and Functional Recovery of Workers, 2nd Ed. American College of Occupational and Environmental Medicine Press, Elk Grove Village, 2007.
178. American College of Occupational and Environmental Medicine (ACOEM) Chronic Pain. In Occupational Medicine Practice Guidelines: Evaluation and Management of Common Health Problems and Functional Recovery of Workers, Second Edition. American College of Occupational and Environmental Medicine Press, Elk Grove Village, ILm 2008.
179. Manchikanti L, Singh V, Derby R, Helm S, Trescot AM, Staats PS, Prager JP, Hirsch JA. Review of occupational medicine practice guidelines for interventional pain management and potential implications. Pain Physician 2008; 11:271-289.
180. Manchikanti L, Singh V, Helm S, Trescot AM, Hirsch JA. A critical appraisal of 2007 American College of Occupational and Environmental Medicine (ACOEM) practice guidelines for interventional pain management: An independent review utilizing AGREE, AMA, IOM, and other criteria. Pain Physician 2008; 11:291-310.
181. Manchikanti L, Singh V, Derby R, Schultz DM, Benyamin RM, Prager JP, Hirsch JA. Reassessment of evidence synthesis of occupational medicine practice guidelines for interventional pain management. Pain Physician 2008; 11:393-482.
182. Manchikanti L, Falco FJE, Boswell MV, Hirsch JA. Facts, fallacies, and politics of comparative effectiveness research: Part 1. Basic considerations. Pain Physician 2010; 13:E23-E54.
183. Manchikanti L, Falco FJE, Boswell MV, Hirsch JA. Facts, fallacies, and politics of comparative effectiveness research: Part 2. Implications for interventional pain management. Pain Physician 2010; 13:E55-E79.
184. Manchikanti L, Derby R, Wolfer LR, Singh V, Datta S, Hirsch JA. Evidencebased medicine, systematic reviews, and guidelines in interventional pain management: Part 5. Diagnostic accuracy studies. Pain Physician 2009; 12:517-540.
185. Manchikanti L, Datta S, Smith HS, Hirsch JA. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 6. Systematic reviews and meta-analyses of observational studies. Pain Physician 2009; 12:819-850.
186. Manchikanti L, Derby R, Wolfer LR, Singh V, Datta S, Hirsch JA. Evidencebased medicine, systematic reviews, and guidelines in interventional pain management: Part 7: Systematic reviews and meta-analyses of diagnostic accuracy studies. Pain Physician 2009; 12:929-963.
187. Manchikanti L, Singh V, Boswell MV. Interventional pain management at crossroads: The perfect storm brewing for a new decade of challenges. Pain Physician 2010; 13:E111-E140.
188. Benyamin RM, Datta S, Falco FJE. A perfect storm in interventional pain management: Regulated, but unbalanced. Pain Physician 2010; 13:109-116.
189. Manchikanti L, Hirsch JA. Obama health care for all Americans: Practical implications. Pain Physician 2009; 12:289-304.
190. Friedly J, Chan L, Deyo R. Increases in lumbosacral injections in the Medicare population: 1994 to 2001. Spine (Phila Pa 1976) 2007; 32:1754-1760.
191. Manchikanti L, Singh V, Pampati V, Smith HS, Hirsch JA. Analysis of growth of interventional techniques in managing chronic pain in Medicare population: A 10-year evaluation from 1997 to 2006. Pain Physician 2009; 12:9-34.
192. Manchikanti L, Pampati V, Singh V, Boswell MV, Smith HS, Hirsch JA. Explosive growth of facet joint interventions in the Medicare population in the United States: A comparative evaluation of 1997, 2002, and 2006 data. BMC Health Serv Res 2010; 10:84.
193. Manchikanti L, Pampati V, Boswell MV, Smith HS, Hirsch JA. Analysis of the growth of epidural injections and costs in the Medicare population: A comparative evaluation of 1997, 2002, and 2006 data. Pain Physician 2010; 13:199-212.
194. Manchikanti L, Cash KA, McManus CD, Pampati V, Singh V, Benyamin RM. The preliminary results of a comparative effectiveness evaluation of adhesiolysis and caudal epidural injections in managing chronic low back pain secondary to spinal stenosis: A randomized, equivalence controlled trial. Pain Physician 2009; 12:E341-E354.
195. Manchikanti L, Singh V, Cash KA, Pampati V, Datta S. A comparative effectiveness evaluation of percutaneous adhesiolysis and epidural steroid injections in managing lumbar post surgery syndrome: A randomized, equivalence controlled trial. Pain Physician 2009; 12: E355-E368.
196. Manchikanti L, Cash KA, McManus CD, Pampati V, Smith HS. Preliminary results of randomized, equivalence trial of fluoroscopic caudal epidural injections in managing chronic low back pain: Part 1. Discogenic pain without disc herniation or radiculitis. Pain Physician 2008; 11:785-800.
197. Manchikanti L, Singh V, Cash KA, Pampati V, Damron KS, Boswell MV. Preliminary results of randomized, equivalence trial of fluoroscopic caudal epidural injections in managing chronic low back pain: Part 2. Disc herniation and radiculitis. Pain Physician 2008; 11:801-815.
198. Manchikanti L, Singh V, Cash KA, Pampati V, Datta S. Preliminary results of randomized, equivalence trial of fluoroscopic caudal epidural injections in managing chronic low back pain: Part 3. Post surgery syndrome. Pain Physician 2008; 11:817-831.
199. Manchikanti L, Cash KA, McManus CD, Pampati V, Abdi S. Preliminary results of randomized, equivalence trial of fluoroscopic caudal epidural injections in managing chronic low back pain: Part 4. Spinal stenosis. Pain Physician 2008; 11:833-848.
200. Manchikanti L, Cash KA, Pampati V, Wargo BW, Malla Y. Cervical epidural injections in chronic discogenic neck pain without disc herniation or radiculitis: Preliminary results of a randomized, double-blind, controlled trial. Pain Physician 2010; 13:E265-E278.
201. Manchikanti L, Cash KA, Pampati V, Wargo BW, Malla Y. The effectiveness of fluoroscopic cervical interlaminar epidural injections in managing chronic cervical disc herniation and radiculitis: Preliminary results of a randomized, doubleblind, controlled trial. Pain Physician 2010; 13:223-236.
202. Manchikanti L, Singh V, Falco FJE, Cash KA, Pampati V. Evaluation of the effectiveness of lumbar interlaminar epidural injections in managing chronic pain of lumbar disc herniation or radiculitis: A randomized, double-blind, controlled trial. Pain Physician 2010; 13:343-355.
203. Manchikanti L, Cash KA, McManus CD, Pampati V, Benyamin R. Preliminary results of a randomized, double-blind, controlled trial of fluoroscopic lumbar interlaminar epidural injections in managing chronic lumbar discogenic pain without disc herniation or radiculitis. Pain Physician 2010; 13:E279-E292.
204. Manchikanti L, Singh V, Falco FJ, Cash KA, Fellows B. Cervical medial branch blocks for chronic cervical facet joint pain: A randomized double-blind, controlled trial with one-year follow-up. Spine (Phila Pa 1976) 2008; 33:1813-1820.
205. Manchikanti L, Singh V, Falco FJE, Cash KA, Pampati V, Fellows B. Comparative effectiveness of a one-year follow-up of thoracic medial branch blocks in management of chronic thoracic pain: A randomized, double-blind active controlled trial. Pain Physician 2010; 13:535-548.
206. Manchikanti L, Cash KA, McManus CD, Pampati V, Benyamin RM. A preliminary report of a randomized double-blind active controlled trial of fluoroscopic thoracic interlaminar epidural injections in managing chronic thoracic pain. Pain Physician 2010; 13:E357-E369.
207. Conn A, Buenaventura R, Datta S, Abdi S, Diwan S. Systematic review of caudal epidural injections in the management of chronic low back pain. Pain Physician 2009; 12:109-135.
208. Parr AT, Diwan S, Abdi S. Lumbar interlaminar epidural injections in managing chronic low back and lower extremity pain: A systematic review. Pain Physician 2009; 12:163-188.
209. Benyamin RM, Singh V, Parr AT, Conn A, Diwan S, Abdi S. Systematic review of the effectiveness of cervical epidurals in the management of chronic neck pain. Pain Physician 2009; 12:137-157.
210. Buenaventura RM, Datta S, Abdi S, Smith HS. Systematic review of therapeutic lumbar transforaminal epidural steroid injections. Pain Physician 2009; 12:233-251.
211. Epter RS, Helm S, Hayek SM, Benyamin RM, Smith HS, Abdi S. Systematic review of percutaneous adhesiolysis and management of chronic low back pain in post lumbar surgery syndrome. Pain Physician 2009; 12:361-378.
212. Hayek SM, Helm S, Benyamin RM, Singh V, Bryce DA, Smith HS. Effectiveness of spinal endoscopic adhesiolysis in post lumbar surgery syndrome: A systematic review. Pain Physician 2009; 12:419-435.
213. Hirsch JA, Singh V, Falco FJE, Benyamin RM, Manchikanti L. Automated percutaneous lumbar discectomy for the contained herniated lumbar disc: A systematic assessment of evidence. Pain Physician 2009; 12:601-620.
214. Singh V, Manchikanti L, Benyamin RM, Helm S, Hirsch JA. Percutaneous lumbar laser disc decompression: A systematic review of current evidence. Pain Physician 2009; 12:573-588.
215. Singh V, Benyamin RM, Datta S, Falco FJE, Helm S, Manchikanti L. Systematic review of percutaneous lumbar mechanical disc decompression utilizing Dekompressor. Pain Physician 2009; 12:589-599.
216. Manchikanti L, Derby R, Benyamin RM, Helm S, Hirsch JA. A systematic review of mechanical lumbar disc decompression with nucleoplasty. Pain Physician 2009; 12:561-572.
217. Helm S, Hayek S, Benyamin RM, Manchikanti L. Systematic review of the effectiveness of thermal annular procedures in treating discogenic low back pain. Pain Physician 2009; 12:207-232.
218. Rupert MP, Lee M, Manchikanti L, Datta S, Cohen SP. Evaluation of sacroiliac joint interventions: A systematic appraisal of the literature. Pain Physician 2009; 12:399-418.
219. Atluri S, Datta S, Falco FJE, Lee M. Systematic review of diagnostic utility and therapeutic effectiveness of thoracic facet joint interventions. Pain Physician 2008; 11:611-629.
220. Falco FJE, Erhart S, Wargo BW, Bryce DA, Atluri S, Datta S, Hayek SM. Systematic review of diagnostic utility and therapeutic effectiveness of cervical facet joint interventions. Pain Physician 2009; 12:323-344.
221. Datta S, Lee M, Falco FJE, Bryce DA, Hayek SM. Systematic assessment of diagnostic accuracy and therapeutic utility of lumbar facet joint interventions. Pain Physician 2009; 12:437-460.
222. Frey ME, Manchikanti L, Benyamin RM, Schultz DM, Smith HS, Cohen SP. Spinal cord stimulation for patients with failed back surgery syndrome: A systematic review. Pain Physician 2009; 12:379-397.
223. Patel VB, Manchikanti L, Singh V, Schultz DM, Hayek SM, Smith HS. Systematic review of intrathecal infusion systems for long-term management of chronic non-cancer pain. Pain Physician 2009; 12:345-360.
224. Nath S, Nath CA, Pettersson K. Percutaneous lumbar zygapophysial (facet) joint neurotomy using radiofrequency current, in the management of chronic low back pain: A randomized doubleblind trial. Spine (Phila Pa 1976) 2008; 33:1291-1298.
225. Manchikanti L, Boswell MV, Rivera JJ, Pampati V, Damron KS, McManus CD, Brandon DE, Wilson SR. A randomized, controlled trial of spinal endoscopic adhesiolysis in chronic refractory low back and lower extremity pain. BMC Anesthesiol 2005; 5:10.
226. Manchikanti L, Rivera JJ, Pampati V, Damron KS, McManus CD, Brandon DE, Wilson SR. One day lumbar epidural adhesiolysis and hypertonic saline neurolysis in treatment of chronic low back pain: A randomized, double-blind trial. Pain Physician 2004; 7:177-186.
227. Pampati S, Cash KA, Manchikanti L. Accuracy of diagnostic lumbar facet joint nerve blocks: A 2-year follow-up of 152 patients diagnosed with controlled diagnostic blocks. Pain Physician 2009; 12:855-866.
228. Manchikanti L, Pampati S, Cash KA. Making sense of accuracy of diagnostic lumbar facet joint nerve blocks: An assessment of implications of 50% relief, 80% relief, single block or controlled diagnostic blocks. Pain Physician 2010; 13:133-143.
229. Manchikanti L, Singh V, Cash KA, Pampati V, Datta S. Management of pain of post lumbar surgery syndrome: Oneyear results of a randomized, double blind controlled trial of fluoroscopic caudal epidural injections. Pain Physician 2010; 13:509-521.
230. Gerges FJ, Lipsitz SR, Nedeljkovic SS. A systematic review on the effectiveness of the nucleoplasty procedure for discogenic pain. Pain Physician 2010; 13:117-132.
231. Graziotti P, Goucke R, for the Directors of the Australian Pain Society. The use of oral opioids in patients with chronic nonmalignant pain: Management strategies. Perth, Australia: Australian Pain Society; 2002. www.apsoc.org.au/pdfs/opioid.pdf.
232. Chapman CR, Lipschitz DL, Angst MS, Chou R, Denisco RC, Donaldson GW, Fine PG, Foley KM, Gallagher RM, Gilson AM, Haddox JD, Horn SD, Inturrisi CE, Jick SS, Lipman AG, Loeser JD, Noble M, Porter L, Rowbotham MC, Schoelles KM, Turk DC, Volinn E, Von Korff MR, Webster LR, Weisner CM. Opioid pharmacotherapy for chronic non-cancer pain in the united states: a research guideline for developing an evidence-base. J Pain 2010; 11:807-829.